FRESENIUS MEDICAL CARE AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.9 EUR | +2.36% |
|
+12.71% | +5.11% |
| Apr. 23 | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Warburg Research reiterates its Sell rating | ZD |
| Apr. 23 | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank gives a Neutral rating | ZD |
| Sales 2024 * | 19.65B 21.03B | Sales 2025 * | 20.36B 21.79B | Capitalization | 11.71B 12.53B |
|---|---|---|---|---|---|
| Net income 2024 * | 711M 761M | Net income 2025 * | 972M 1.04B | EV / Sales 2024 * | 1.1 x |
| Net Debt 2024 * | 9.86B 10.55B | Net Debt 2025 * | 9.22B 9.87B | EV / Sales 2025 * | 1.03 x |
| P/E ratio 2024 * |
16.6
x | P/E ratio 2025 * |
12.1
x | Employees | 119,845 |
| Yield 2024 * |
2.73% | Yield 2025 * |
3.28% | Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fresenius Medical Care AG
More recommendations
More press releases
| 1 day | +2.36% | ||
| 1 week | +12.71% | ||
| Current month | +11.92% | ||
| 1 month | +15.28% | ||
| 3 months | +9.89% | ||
| 6 months | +19.96% | ||
| Current year | +5.11% |
1 week
34.89
40.38
1 month
34.1240.38
Current year
33.8841.62
1 year
30.1649.62
3 years
25.9571.14
5 years
25.9581.10
10 years
25.9593.82
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 19-10-31 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 23-09-30 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 08-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 16-05-11 |
Shervin Korangy
BRD | Director/Board Member | 50 | 23-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 23-07-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | -.--% | ||
| 1.12% | 2 M€ | +13.56% | - | |
| 0.80% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 39.9 | +2.36% | 801,792 |
| 24-04-22 | 38.98 | +6.44% | 750,876 |
| 24-04-19 | 36.62 | +0.52% | 803,997 |
| 24-04-18 | 36.43 | +2.50% | 663,964 |
| 24-04-17 | 35.54 | +1.57% | 318,946 |
Delayed Quote Xetra, April 23, 2024 at 11:35 am EDT
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-05-06
- Q1 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.9
EUR
Average target price
39.01
EUR
Spread / Average Target
-2.24%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.11% | 12.17B | |
| -13.25% | 87.77B | |
| +18.01% | 82.08B | |
| +11.97% | 30.03B | |
| -8.50% | 17.08B | |
| -1.46% | 16.41B | |
| +4.44% | 12.37B | |
| -31.05% | 11.89B | |
| +27.83% | 11.62B | |
| +8.18% | 10.85B |
- Stock Market
- Equities
- FME Stock
